Lesson 7
Lesson 7
Antibody
Production
Antibodies
 Antibodies are proteins that recognise and
bind to specific antigens
 Antigens are foreign substances that
stimulate the production of antibodies
 Many of the molecules on the surface of
viruses and bacteria are antigens
Antigen
Microbe
Macrophage
MHC protein
receptor
Helper T-cell
Antibody
SIGNAL
Step 4: Proliferation
The activated B-cell starts to divide
by mitosis to form a clone of plasma
cells.
Plasma cells are activated B-cells
with a very extensive network of
rough endoplasmic reticulum.
Plasma cells synthesis large
amounts of antibody, which they
excrete by exocytosis.
Antigen
Antigen
Activate
B-cell
Clone
Memory
Cell
Activate
Helper
T-cell
Antibody Production:
Summary
Plasma
Cell
Macrophage
Antibodies
Vaccine	Development	
Traditional and Modern
Approaches
Purpose of Vaccina6on
18
Purpose of Vaccina6on
Staphylococcus epidermidis
Normal
colon
Bacterial colonization of
the body
per gm or cm2
Bacterial
Bifidobacterium bifidum
E.coli
Tetanus
Clostridium tetani
Whooping cough
Bordetella pertussis
Cholera
Vibrio cholerae
TOXIN PRODUCED
Diphtheria toxin
Tetanus toxin
Adenylate cyclase toxin
Pertussis toxin
Cholera enterotoxin
Invasion of Cells
Vaccine manufacture
Antigen Production
Eggs
Inuenza
Cell culture
Vaccine Processing
An6gen	concentra6on.	
Removal	of	unwanted	foreign	components.	
 Host	proteins	
 Host	DNA	
 Adven66ous	agents	
 LPS	
 Unwanted	proteins	(not	involved	in	immunity)	
 Unwanted	nucleic	acid	
Growth
of
Virus, Yeast
or Bacteria
Eggs
Clarification
Concentra1on
Purica1on
Depth	lter	
Crossow	
ltra1on	
Chromatography	
Ion	exchange	
Bacterial / Yeast
Crossow ltra1on
Hydrophobic	
Anity	
Fermenta1on	
Ultracentrifuga1on	
Cell culture
Centrifuge
Size exclusion
Chemical	
Formaldehyde
precipita1on
Inactivation
PL
Antigen
presentation
DT
Formulation
CONHNHCO(CH2)4CONHNHOC-
Vi-CPS
CONJUGATES
Combining antigen(s)
Combining with
adjuvant
Stabilizers
ISCOMS
Preservatives
Cryo-protectants
ADJUVANTS
VIROSOMES
Types of Vaccines
29
Types of Vaccines
Inac6vated	toxins	
Inac6vated	whole	bacteria	or	viruses	
Live	aRenuated	bacteria	or	viruses		
Subunit	vaccines	
Gene6cally	engineered	proteins	
Polysaccharide	vaccines	
Conjugated	vaccines	
Recombinant	DNA	modied	organisms	
DNA	vaccines	
30
Inac6vated	Toxins	
 Exotoxin	
 Gram	nega6ve	and	gram	
posi6ve	bacteria.	
 Heat	Labile.	
 Protein.	
 Secreted	by	the	bacteria.	
 Endotoxin	
 Gram	nega6ve	bacteria.	
 Heat	stable.	
 Lipopolysaccharide.	
 Firmly	bound	to	the	
bacteria	outer	membrane.	
31
Toxoid	
 Not	a	vaccine	against	the	organism.	
 Vaccine	against	pathogenic	exotoxin.	
 Tetanus,	diphtheria,	(pertussis?),	anthrax?	
 Purify	toxin	then	chemically	inac6vate	(toxoid)	
 Risk	of	incomplete	inac6va6on.	
 TT,	DT.	
Inactivated Toxins
Diphtheria toxin
inhibits protein
synthesis resulting in
cell death
33
Tetanus
34
Tetanus
Clostridium	tetani	
Gram	posi6ve	drum	s6ck	shaped	rod	
Not	transmiRed	from	person	to	person	
Transmission	via	contaminated	wounds	
Found	in	soil	and	animal	feces	
Replicate	in	low	oxygen	environment	
Release	toxin	which	enters	bloodstream	
Acts	on	the	nervous	system	to	block	
neurotransmiRers	
35
Tetanus	
 The	toxin	causes	the	disease.		
 The	vaccine	consists	of	toxin	which	is	rendered	inac6ve	
(toxoid)	but	retains	immunogenicity.		
 The	immune	response	to	the	vaccine	is	directed	against	the	
toxin	rather	than	the	bacteria.	
 Vaccina6on	results	in	serum	an6body	produc6on.		The	
an6body	neutralizes	toxin.	
 Three	doses	of	vaccine	recommended	to	raise	an6body	levels	
to	protec6ve	levels.	
 Immunity	lasts	about	10	years.	
 Vaccina6on	prevents	disease	but	is	incapable	of	disease	
eradica6on.	
36
Diphtheria
38
Diphtheria	
 Corynebacterium	diphtheriae.	
 Gram	posi6ve	bacillus.	
 Only	produces	a	powerful	exotoxin	when	infected	
with	a	bacteriophage.	(the	phage	carries	the	toxin	
gene	which	coverts	the	bacteria	from	non-toxigenic	
to	toxigenic)	
 Diphtheria	is	now	well	controlled	by	na6onal	
immuniza6on	programs.	
 Only	receives	aRen6on	when	rou6ne	immuniza6on	
programs	fall.	
39
Diphtheria
40
Recombinant	
 Advantage	
 Safe.	Growth	in	non	pathogenic	yeast	cells	
 Easier		in	case	of	dicult	to	grow	viruses	like	
hepB,	HPV.		
 Disadvantages:	
 Need	to	iden6fy	protec6ve	an6gen/s	
 Obtaining	an6gen	in	'correct'	conforma6on	
 Usually	poorly	immunogenic	alone	
 Poor	CMI		requires	adjuvant.	
41
Recombinant Vaccines
E.coli
S. cerevisiae
42
Recombinant Vaccine
43
Recombinant	Vaccine	
 The	gene	coding	for	HBsAg	was	discovered	in	
1970.	
 The	gene	has	been	inserted	into	a	yeast	cell.	
 As	the	yeast	cell	grows	it	produces	large	
amounts	of	HBsAg.	
 The	HBsAg	is	extracted	and	puried	then	
incorporated	into	the	vaccine.		
44
Recombinant	Vaccine	
 Advantages	of	the	recombinant	vaccines.	
 Produced	more	quickly.	
 In	larger	quan66es.	
 Free	from	infec6ous	virus	par6cles.	
45
Vaccinia virus
expressing papilloma
virus antigens on its
surface.
47
DNA	Vaccines	
 Involves	the	injec6on	of	naked	DNA	coding	for	
one	or	more	genes.	
 The	gene	is	grahed	onto	another	piece	of	DNA	
which	acts	as	a	vector.	
 Injected	into	muscle	6ssue,	once	in	the	cell	
the	gene	prompts	the	cell	to	produce	an6gen.	
 The	immune	system	then	mounts	an	immune	
response.	
48
DNA Vaccines
Viral
protein
mRNA
Antibodyproducing cell
Nucle
us
Injected
DNA coding
for a specific
Class1
antigen
MHC
Cytotoxic Tlymphocyte
49
DNA	Vaccines	
 Clinical	trials	to	date	with	naked	DNA	vaccines	
have	not	proved	to	be	that	successful	
 DNA	vaccines	may	be	useful	as	a	priming	dose	
in	prime-boost	regimes	due	to	their	ability	to	
induce	cell	mediated	immune	responses.	
50
Protein	Purica6on	
 The	aim	of	protein	purica6on	is	to	isolate	
one	par6cular	protein	from	all	the	others	in	
the	star6ng	material.		
 A	combina6on	of	frac6ona6on	techniques	is	
used	that	exploits	the	solubility,	size,	charge	
or/and	specic	binding	anity	of	the	protein	
of	interest.		
Stabiliza6on	of	Protein	
 Certain	precau6ons	have	to	be	taken	in	order	
to	prevent	proteins	being	denatured	or	
inac6vated	during	purica6on	by	physical	or	
biological	factors.		
 These	include	buering	the	pH	of	the	
solu6ons,	undertaking	the	procedures	at	a	low	
temperature	and	including	protease	inhibitors	
to	prevent	unwanted	proteolysis.		
Assay	of	Protein	
 In	order	to	monitor	the	progress	of	the	
purica6on	of	a	protein	it	is	necessary	to	have	
an	assay	for	it.		
 Depending	on	the	protein,	the	assay	may	
involve	measuring	the	enzyme	ac6vity	or	
ligand-binding	proper6es,	or	may	quan6fy	the	
protein	present	using	an6bodies	directed	
against	it.		
	
8
9
30111
1
Dialysis
2
3
4
5
6
7
8
9
40111
1
2
3
4
5
6
7
8
9
50
5111
Dialysis	
 Proteins	can	be	separated	
from	small	molecules	by	
dialysis	through	a	semi-	
permeable	membrane	
which	has	pores	that	allow	
small	molecules	to	pass	
through	but	not	proteins.		
	
(b)
Ultracentrifuga6on	
 Proteins	with	large	
dierences	in	
molecular	mass	can	
be	separated	by	
ratezonal	
centrifuga6on	using	
a	gradient	of	a	
dense	material	such	
as	sucrose.		
	
(A)
armored
chamber
sedimenting
material
(B)
sedimenting
material
hinge
cell
homogenate
rotor
LOW-SPEED CENTRIFUGATION
refrigeration
pellet contains
whole cells
nuclei
cytoskeletons
SUPERNATANT SUBJECTED TO
MEDIUM-SPEED CENTRIFUGATION
pellet contains
mitochondria
lysosomes
peroxisomes
SUPERNATANT SUBJECTED TO
HIGH-SPEED CENTRIFUGATION
pellet contains
microsomes
small vesicles
SUPERNATANT SUBJECTED TO
VERY-HIGH-SPEED CENTRIFUGATION
pellet contains
ribosomes
viruses
large
macromolecules
motor
vacuum
refrigeration
motor
vacuum
Figure 85 The preparative ultracentrifuge. (A) The sample is contained in tubes that are
inserted
into a ring of angled cylindrical holes in a metal rotor. Rapid rotation of the rotor generates
PURIFYING
PROTEINS
enormous centrifugal forces, which cause particles in the sample to sediment against the bottom
sides of the sample tubes, as shown here. The vacuum reduces friction, preventing heating of the
rotor and allowing the refrigeration system to maintain the sample at 4C. (B) Some fractionation
(A)
(B)
methods require a different type of rotor called a swinging-bucket rotor. In this case, the sample
EQUILIBRIUM
VELOCITY
MBoC6
tubes
are placed in metal tubes on hinges
that m8.09/8.07
allow the tubes to swing
outward when the rotor
SEDIMENTATION
SEDIMENTATION
spins. Sample tubes are therefore horizontal during spinning, and samples are sedimented toward
the bottom, not the sides, of the tube, providing better separation of differently sized components
sample
(see Figures 86 and
87).
sample
stabilizing shallow
sucrose
LOW-SPEED CEN
gradient
steep
(e.g.,
520%)
sucrose
Centrifugation
is the
first step in most fractionations, but it separates only
comgradient
ponents that differ greatly in size. A finer degree of separation can be achieved
(e.g., by
2070%)
layering the homogenate in a thin band on top of a salt solution that fills a centricentrifuged, the various components in the mixture move as a
series of distinct bands through the solution, each at a different rate, in a process
called velocity sedimentation (Figure 87A). For the procedure to work effectively,
the bands mustslow-sedimenting
be protected from convective mixing, which would normally
SUPERNATANT S
occur whenevercomponent
a denser solution (for example, one containing organelles) finds
MEDIUM-SPEED
itself on top of afast-sedimenting
lighter one (the salt solution). This is achieved by augmenting
component
the solution in the
tube with a shallow gradient of sucrose prepared by a special
mixing device. The resulting density gradientwith the dense end at the bottom
of the tubekeeps each region of the solution denser than any solution above it,
FRACTIONATION
and it thereby prevents convective mixing from distorting the separation.
When sedimented through sucrose gradients, different cell components sepalow-buoyantrate into distinct bands that can be collected individually. The relative rate at
which
density
each component sediments depends primarily on its size and shapenormally
component SUPERNATANT S
HIGH-SPEED CEN
being described in terms of its sedimentation coefficient, or S value. Present-day
high-buoyantultracentrifuges rotate at speeds of up to 80,000 rpm and produce forces asdensity
high as
component
500,000 times gravity. These enormous forces drive even small macromolecules,
such as tRNA molecules and simple enzymes, to sediment at an appreciable rate
and allow them to be separated from one another by size.
The ultracentrifuge is also used to separate cell components on the basis of
their buoyant density, independently of their size and shape. In this case, the
CENTRIFUGATION
fuge tube. When
SUPERNATANT S
VERY-HIGH-SPEE
Figure 86 Cell fractionation by centrifugation. Repeated centrifugation
at progressively higher speeds will fractionate homogenates of cells into their
sample is sedimented through
a general,
steepthedensity
gradient
that contains
a very high
components. In
smaller the subcellular
component,
the greater
concentration of sucrose
cesium
chloride.
Each
cellvalues
component
the or
centrifugal
force required
to sediment
it. Typical
for the variousbegins to move
1111
2
3
4
5
6
7
8
9
10111
1
2
3
4
5
Porous
beads
Mixture of
proteins
Large
molecules
Small
molecules
Glass/
plastic
column
Tube to
collect
protein
Large
Small
sample
applied
solvent continuously
applied to the top of
column from a large
reservoir of solvent
solid
matrix
porous
plug
test
tube
time
fractionated molecules
eluted and collected
Figure 88
by column
a solution c
molecules,
cylindrical g
a permeable
A large amo
slowly throu
in separate
bottom. Bec
the sample
the column,
different tub
+
Positively
charged
beads
+
+
+
Glass
column
Buffer
Mixture of
proteins
(a)
+
+
+
+
+
+
NaCl
+
+
+
Positively
charged
proteins
Negatively
charged
proteins
+
+
+ Cl
 +
Cl
+
+
Cl
+
+
Cl
+
+
+
+
+
+
+
+
+
+
+
Tubes to
collect
protein
Negatively
charged
proteins
Anity Chromatography
Ligand
immobilized
on insoluble
support and
packed in
glass column
Mixture of
different
proteins
Specific
protein
binds to
ligand
Unwanted
proteins pass
straight through
Soluble ligand
added
Specific
protein elutes
off bound to
soluble ligand
PURIFYING PROTEINS
solvent flow
+ ++
positively
+
+
charged
+
+
+
+
bead
+ +
+ +
+
+ +
+
+
+
+ bound
+
+++
negatively
+ +++
+ + charged
+ +
molecule
+
+
+
+
+
free
+++ +
+
positively
+ +
+
charged
molecule
449
solvent flow
solvent flow
porous bead
retarded
small molecule
unretarded
large molecule
bead with
covalently
attached
substrate
bound
enzyme
molecule
other proteins
Na6ve	PAGE	
 In	na6ve	polyacrylamide	
gel	electrophoresis	(PAGE)	
proteins	are	applied	to	a	
porous	polyacrylamide	gel	
and	separated	in	an	electric	
eld	on	the	basis	of	their	
net	nega6ve	charge	and	
their	size.		
 Small/more	nega6vely	
charged	proteins	migrate	
further	through	the	gel	
than	larger/less	nega6vely	
charged	proteins.		
SDS-PAGE	
 In	SDS-PAGE,	the	protein	sample	is	treated	with	a	reducing	
agent	to	break	disulde	bonds	and	then	with	the	anionic	
detergent	sodium	dodecyl	sulfate	(SDS)	which	denatures	
the	proteins	and	covers	them	with	an	overall	nega6ve	
charge.		
 The	sample	is	then	frac6onated	by	electrophoresis	through	
a	polyacrylamide	gel.		
 As	all	the	proteins	now	have	an	iden6cal	charge	to	mass	
ra6o,	they	are	separated	on	the	basis	of	their	mass.		
 The	smallest	proteins	move	farthest.		
 SDS-PAGE	can	be	used	to	determine	the	degree	of	purity	of	
a	protein	sample,	the	molecular	mass	of	a	protein	and	the	
number	of	polypep6de	subunits	in	a	protein.		
(B)
sample loaded onto gel
by pipette
plastic casing
plastic casing
buffer
gel
buffer
+ anode
+ anode
single-subunit
single-subunit
protein
protein
C
C
Figure
813 SDS polyacrylamide-gel
electrophoresis(A)
(SDS-PAGE).
(A) An
de-gel
electrophoresis
(SDS-PAGE).
An
B
electrophoresis
apparatus.chains
(B) Individual
polypeptide
chains form a complex
ndividual
polypeptide
form
a complex
negativelydodecyl
charged molecules
of sodium
dodecyl
sulfate (SDS) and
es ofwith
sodium
sulfate
(SDS)
and
C
therefore
migrate
as
a
negatively
charged
SDSprotein
complex
through a
y charged SDSprotein complex through
a
porous
gel speed
of polyacrylamide.
Because theunder
speed ofthese
migration under these
ecause
the
of migration
conditions
is
greater
the
smaller
the
polypeptide,
this
the polypeptide, this technique can betechnique
used can be used
to
determine
the
approximate
molecular
weight
of
a
polypeptide
chain as
molecular weight of a polypeptide chain as
A
well
as
the
subunit
composition
of
a
protein.
If
the
protein
contains
a large
of a protein. If the protein contains a large
of carbohydrate,
however, it will
the gel and its
er, it amount
will move
anomalously
onmove
theanomalously
gel andon
its
apparent molecular weight estimated by SDS-PAGE will be misleading. Other
mated by SDS-PAGE will be misleading. Other
modifications, such as phosphorylation, can also cause small changes in a
rylation, can also cause small changes in a
proteins migration in the gel.
B
C
+
slab of polyacrylamide gel
slab of polyacrylamide gel
Isoelectric	Focusing	
 In	isoelectric	focusing,	
proteins	are	separated	by	
electrophoresis	in	a	pH	
gradient	in	a	gel.		
 They	separate	on	the	basis	of	
their	rela6ve	content	of	
posi6vely	and	nega6vely	
charged	residues.		
 Each	protein	migrates	
through	the	gel	un6l	it	
reaches	the	point	where	it	
has	no	net	charge,	its	
isoelectric	point	(pI).		
Western	Blot	
 A	specic	protein	of	
interest	can	be	
detected	by	
immunoblot	(Western	
blot)	following	its	
transfer	from	the	gel	to	
nitrocellulose	using	an	
an6body	that	
specically	recognizes	
it.		
 This	primary	an6body	is	
then	detected	with	
either	a	radiolabeled	or	
enzyme-linked	
secondary	an6body.		
Edman	Degrada6on	
 The	N-terminal	amino	acid	of	a	protein	can	be	
determined	by	reac6ng	the	protein	with	dansyl	
chloride	or	uorodinitrobenzene	prior	to	acid	
hydrolysis.		
 The	amino	acid	sequence	of	a	protein	can	be	
determined	by	Edman	degrada6on	which	sequen6ally	
removes	one	residue	at	a	6me	from	the	N	terminus.		
 This	uses	phenyl	isothiocyanate	to	label	the	N-terminal	
amino	acid	prior	to	its	release	from	the	protein	as	a	
cyclic	phenylthiohydantoin	amino	acid.		
Edman	Degrada6on	
 In	order	to	sequence	an	en6re	protein,	the	polypep6de	chain	has	to	
be	broken	down	into	smaller	fragments	using	either	chemicals	(e.g.	
cyanogen	bromide)	or	enzymes	(e.g.	chymotrypsin	and	trypsin).		
 The	resul6ng	smaller	fragments	are	then	sequenced	by	Edman	
degrada6on.		
 The	complete	sequence	is	assembled	by	analyzing	overlapping	
fragments	generated	by	cleaving	the	polypep6de	with	dierent	
reagents.		
 Aminopep6dase	and	carboxypep6dase	release	the	N-	and	Cterminal	amino	acids	from	a	protein,	respec6vely.		
 The	polypep6des	in	a	mul6-subunit	protein	have	to	be	dissociated	
and	separated	prior	to	sequencing	using	urea	or	guanidine	
hydrochloride	which	disrupt	noncovalent	interac6ons,	and	2mercaptoethanol	or	dithiothreitol	that	break	disulde	bonds.		
+
+
+
+
ion source
+ +
+
+
+
+ +
mass
analyzer
+
+
relative abundance
100
detector
1000
inert gas
+
+
+
+
ion source
+
+
+
MS2
+
+
2500
100
peptide
mixture
MS1
1500
2000
mass-to-charge ratio (m/z)
relative abundance
456
200
600
mass-to-charge ratio (m/z)
1000